BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1683737)

  • 1. Effects of alpha 2-adrenoceptor blockade and thyrotropin-releasing hormone (TRH) on the cardiovascular system in the rabbit.
    Seligsohn EE; Koskinen LO
    Acta Physiol Scand; 1991 Oct; 143(2):187-94. PubMed ID: 1683737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic and non-adrenergic cardiovascular effects of thyrotropin-releasing hormone (TRH) in the anaesthetized rabbit.
    Seligsohn EE
    Acta Physiol Scand; 1992 Sep; 146(1):107-17. PubMed ID: 1359733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone (TRH) causes sympathetic activation and cerebral vasodilation in the rabbit.
    Koskinen LO; Bill A
    Acta Physiol Scand; 1984 Oct; 122(2):127-36. PubMed ID: 6097095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries.
    Kopia GA; Kopaciewicz LJ; Ruffolo RR
    J Pharmacol Exp Ther; 1986 Dec; 239(3):641-7. PubMed ID: 2879028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of yohimbine and idazoxan on the systemic and regional hemodynamics of waking rats].
    Ivashev MN; Medvedev OS; Giulumian AD
    Farmakol Toksikol; 1991; 54(5):20-2. PubMed ID: 1686868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NG-nitro-L-arginine methyl ester on the cardiovascular system of the anaesthetized rabbit and on the cardiovascular response to thyrotropin-releasing hormone.
    Seligsohn EE; Bill A
    Br J Pharmacol; 1993 Aug; 109(4):1219-25. PubMed ID: 8401932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral and ocular blood flow during alpha 2-blockade: evidence for a modulated sympathetic response.
    Linder J
    Acta Physiol Scand; 1981 Dec; 113(4):511-7. PubMed ID: 6127865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of TRH on cerebral and peripheral blood flows; role of submesencephalic brain stem centres.
    Koskinen LO
    Acta Physiol Scand; 1986 Oct; 128(2):277-88. PubMed ID: 3096078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.
    Sirén AL; Lake CR; Feuerstein G
    Circ Res; 1988 Jan; 62(1):139-54. PubMed ID: 2891452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRH-induced blood flow and mean arterial pressure changes in the rabbit are not dependent on the anaesthetic used.
    Hugoson-Seligsohn EE; Koskinen LO
    Br J Pharmacol; 1989 May; 97(1):190-6. PubMed ID: 2497924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows.
    Koskinen LO
    Br J Pharmacol; 1986 Mar; 87(3):509-19. PubMed ID: 3099875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone and TRH affect regional blood flows in the anesthetized rabbit.
    Koskinen LO
    Peptides; 1991; 12(6):1273-7. PubMed ID: 1815213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y (NPY): a vasoconstrictor in the eye, brain and other tissues in the rabbit.
    Nilsson SF
    Acta Physiol Scand; 1991 Apr; 141(4):455-67. PubMed ID: 1678907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of muscarinic and prostaglandic mechanisms on regional cerebral and peripheral blood flows and on the vascular effects of thyrotropin releasing hormone (TRH).
    Koskinen LO
    Acta Physiol Scand; 1994 Dec; 152(4):399-406. PubMed ID: 7701940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.
    Medgett IC; Langer SZ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):823-30. PubMed ID: 6144792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
    Branch CA; Knuepfer MM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):742-51. PubMed ID: 1359113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor and cardiovascular effects of selective alpha 2-adrenoceptor antagonists in the decerebrated rabbit.
    Harris J; Clarke RW
    Eur J Pharmacol; 1993 Jun; 237(2-3):323-8. PubMed ID: 8103464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.